BioSpace News Archive

Medtronic Announces First Economic Analysis Demonstrating Benefits of Professional CGM in People With Type 2 Diabetes

Data from the study demonstrated significant cost avoidance to the healthcare system when used during a therapy change or when used at least twice per year.

October 25, 2017
·
4 min read
Policy

NW Bio Reports Favorable Results and Progress in Resolving Lawsuits

NW Bio is pleased to report meaningful progress in resolving four lawsuits that were brought against it as reported in the Company’s periodic filings.

October 25, 2017
·
6 min read
Policy

Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA

The FDA has requested extra time to review its post-approval drug manufacturing submission that was filed with the FDA September 28, 2017.

October 25, 2017
·
3 min read
Business

IGC to Distribute its Formulations in Germany in Early 2018

India Globalization Capital has entered into a Memorandum of Understandingwith MediCann Handels GmbH.

October 25, 2017
·
1 min read
Quotient Scores $40M and Eyes an Additional $49M

Quotient will use the cash to fund the ongoing development and commercial scale up and, if approved, commercialization of MosaiQ.

October 25, 2017
·
3 min read
BioForest

Alligator Bioscience Aptevo Therapeutics: Tumor Antigen 5T4 Associated with Many Forms of Solid Tumors Identified as the Second Target for ALG.APV-527

Alligator Bioscience and Aptevo today announced further details of the companies’ collaboration on ALG.APV-526, a bispecific antibody targeting 4-1BB and a tumor antigen, now identified as 5T4, which is found on various types of cancer cells.

October 25, 2017
·
6 min read